celanese corp. - CE

CE

Close Chg Chg %
72.86 2.15 2.95%

Closed Market

75.01

+2.15 (2.95%)

Volume: 5.05M

Last Updated:

Nov 21, 2024, 3:59 PM EDT

Company Overview: celanese corp. - CE

CE Key Data

Open

$72.78

Day Range

72.34 - 76.12

52 Week Range

71.39 - 172.15

Market Cap

$7.97B

Shares Outstanding

109.31M

Public Float

108.85M

Beta

1.30

Rev. Per Employee

N/A

P/E Ratio

7.32

EPS

$9.99

Yield

384.09%

Dividend

$0.70

EX-DIVIDEND DATE

Oct 30, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

2.56M

 

CE Performance

1 Week
 
1.65%
 
1 Month
 
-41.80%
 
3 Months
 
-43.17%
 
1 Year
 
-43.58%
 
5 Years
 
-39.90%
 

CE Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About celanese corp. - CE

Celanese Corp. engages in the provision of technology and specialty materials businesses. It operates through the following segments: Engineered Materials, Acetate Tow, Acetyl Chain and Other Activities. The Engineered Materials segment includes the engineered materials business, food ingredients business and certain strategic affiliates. The Acetate Tow segment serves consumer-driven applications and is a global producer and supplier of acetate tow and acetate flake used in filter products applications. The Acetyl Chain segment includes the integrated chain of intermediate chemistry, emulsion polymers and ethylene vinyl acetate ("EVA") polymers businesses, based on similar products, production processes, classes of customers and selling and distribution practices as well as economic similarities over a normal business cycle. The Other Activities segment consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expenses associated with financing activities. The company was founded by Camille Dreyfus and Henri Dreyfus in 1918 and is headquartered in Irving, TX.

CE At a Glance

Celanese Corp.
222 West Las Colinas Boulevard
Irving, Texas 75039-5421
Phone 1-972-443-4000 Revenue 10.94B
Industry Chemicals: Specialty Net Income 1.96B
Sector Process Industries 2023 Sales Growth 13.098%
Fiscal Year-end 12 / 2024 Employees 12,410
View SEC Filings

CE Valuation

P/E Current 7.324
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 8.671
Price to Sales Ratio 1.553
Price to Book Ratio 2.386
Price to Cash Flow Ratio 8.949
Enterprise Value to EBITDA 15.366
Enterprise Value to Sales 2.719
Total Debt to Enterprise Value 0.474

CE Efficiency

Revenue/Employee 881,547.139
Income Per Employee 157,937.147
Receivables Turnover 6.132
Total Asset Turnover 0.414

CE Liquidity

Current Ratio 1.527
Quick Ratio 0.948
Cash Ratio 0.443

CE Profitability

Gross Margin 22.358
Operating Margin 11.197
Pretax Margin 10.814
Net Margin 17.916
Return on Assets 7.449
Return on Equity 30.94
Return on Total Capital 9.293
Return on Invested Capital 10.074

CE Capital Structure

Total Debt to Total Equity 198.815
Total Debt to Total Capital 66.535
Total Debt to Total Assets 53.006
Long-Term Debt to Equity 178.057
Long-Term Debt to Total Capital 59.588
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Celanese Corp. - CE

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
5.66B 8.54B 9.67B 10.94B
Sales Growth
-10.20% +50.96% +13.31% +13.10%
Cost of Goods Sold (COGS) incl D&A
4.38B 5.88B 7.40B 8.49B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
349.00M 371.00M 461.00M 711.00M
Depreciation
327.00M 346.00M 399.00M 547.00M
Amortization of Intangibles
22.00M 25.00M 62.00M 164.00M
COGS Growth
-7.17% +34.35% +25.72% +14.85%
Gross Income
1.28B 2.65B 2.28B 2.45B
Gross Income Growth
-19.24% +107.99% -14.20% +7.42%
Gross Profit Margin
+22.56% +31.09% +23.54% +22.36%
2020 2021 2022 2023 5-year trend
SG&A Expense
556.00M 719.00M 936.00M 1.22B
Research & Development
74.00M 86.00M 112.00M 146.00M
Other SG&A
482.00M 633.00M 824.00M 1.07B
SGA Growth
+1.09% +29.32% +30.18% +30.45%
Other Operating Expense
- - - -
-
Unusual Expense
52.00M 7.00M (31.00M) 73.00M
EBIT after Unusual Expense
668.00M 1.93B 1.37B 1.15B
Non Operating Income/Expense
1.69B 420.00M 454.00M 751.00M
Non-Operating Interest Income
6.00M 8.00M 69.00M 39.00M
Equity in Earnings of Affiliates
134.00M 146.00M 220.00M 102.00M
Interest Expense
109.00M 100.00M 405.00M 720.00M
Interest Expense Growth
-8.40% -8.26% +305.00% +77.78%
Gross Interest Expense
117.00M 112.00M 423.00M 757.00M
Interest Capitalized
8.00M 12.00M 18.00M 37.00M
Pretax Income
2.25B 2.25B 1.42B 1.18B
Pretax Income Growth
+127.83% -0.13% -36.79% -16.75%
Pretax Margin
+39.81% +26.33% +14.69% +10.81%
Income Tax
247.00M 330.00M (489.00M) (790.00M)
Income Tax - Current - Domestic
- 13.00M 54.00M 8.00M
Income Tax - Current - Foreign
126.00M 323.00M 306.00M 162.00M
Income Tax - Deferred - Domestic
308.00M (16.00M) (261.00M) (178.00M)
Income Tax - Deferred - Foreign
(200.00M) 23.00M (588.00M) (782.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
134.00M 146.00M 220.00M 102.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.00B 1.92B 1.91B 1.97B
Minority Interest Expense
7.00M 6.00M 8.00M 4.00M
Net Income
2.00B 1.91B 1.90B 1.97B
Net Income Growth
+132.75% -4.26% -0.52% +3.52%
Net Margin Growth
+35.31% +22.40% +19.66% +18.00%
Extraordinaries & Discontinued Operations
(12.00M) (22.00M) (8.00M) (9.00M)
Discontinued Operations
(12.00M) (22.00M) (8.00M) (9.00M)
Net Income After Extraordinaries
1.99B 1.89B 1.89B 1.96B
Preferred Dividends
- - - -
-
Net Income Available to Common
1.99B 1.89B 1.89B 1.96B
EPS (Basic)
16.8481 16.9927 17.4755 18.0066
EPS (Basic) Growth
+145.06% +0.86% +2.84% +3.04%
Basic Shares Outstanding
117.82M 111.22M 108.38M 108.85M
EPS (Diluted)
16.7537 16.8623 17.3387 17.9192
EPS (Diluted) Growth
+145.12% +0.65% +2.83% +3.35%
Diluted Shares Outstanding
118.48M 112.08M 109.24M 109.38M
EBITDA
1.07B 2.31B 1.80B 1.94B
EBITDA Growth
-22.59% +115.72% -21.86% +7.44%
EBITDA Margin
+18.90% +27.01% +18.63% +17.70%

Snapshot

Average Recommendation HOLD Average Target Price 103.474
Number of Ratings 22 Current Quarters Estimate 1.252
FY Report Date 12 / 2024 Current Year's Estimate 8.158
Last Quarter’s Earnings 2.44 Median PE on CY Estimate N/A
Year Ago Earnings 8.92 Next Fiscal Year Estimate 9.549
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 19 9 20 20
Mean Estimate 1.25 1.83 8.16 9.55
High Estimates 1.31 2.00 8.21 11.15
Low Estimate 1.21 1.66 8.12 8.15
Coefficient of Variance 1.97 6.63 0.31 7.31

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 3 5
OVERWEIGHT 2 2 2
HOLD 12 14 13
UNDERWEIGHT 2 2 2
SELL 4 2 1
MEAN Hold Hold Hold

Insider Actions for Celanese Corp. - CE

Date Name Shares Transaction Value
Jul 17, 2024 Mark Christopher Murray SVP - Acetyls 11,129 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $140.58 per share 1,564,514.82
May 15, 2024 Kathryn M. Hill Director 3,918 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Deborah J. Kissire Director 4,722 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Deborah J. Kissire Director 4,710 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Deborah J. Kissire Director 100 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
May 15, 2024 William M. Brown Director 14,826 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 William M. Brown Director 14,769 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 William M. Brown Director 103 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
May 15, 2024 Michael König Director 2,203 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.07 per share 350,431.21
May 15, 2024 Edward G. Galante Director 6,685 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Kathryn M. Hill Director 3,909 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Kathryn M. Hill Director 9,474 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
May 15, 2024 Kim K. W. Rucker Director 8,253 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Kim K. W. Rucker Director 8,225 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Kim K. W. Rucker Director 56 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
May 15, 2024 Jean Stuart Blackwell Director 9,119 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 15, 2024 Jay V. Ihlenfeld Director 10,058 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Celanese Corp. in the News